Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (Official Journal of the European Union L 2024/1860 of 9 July 2024) (195939/EU XXVII.GP)

EU-V: U32 Offizielles Ratsdokument

Regulation (EU) 2024/1860 of the European Parliament and of the Council of 13 June 2024 amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed, the obligation to inform in case of interruption or discontinuation of supply, and transitional provisions for certain in vitro diagnostic medical devices (Official Journal of the European Union L 2024/1860 of 9 July 2024)

Erstellt am 12.09.2024 von: Juristischer Dienst - Qualität der Rechtsetzung

Eingelangt am 12.09.2024, U32 Übermittlung

  Aufklappen
Linkart Link
INT
RMA
RMA
RMA
RMA
RMA
RMA
RMA
VER
VER
  Aufklappen
Interinstitutionelle Zahl
Link
2024/0021 COD
  Aufklappen
Code Sachgebiet
JUR 371 Rechtsfragen
SAN 475 Gesundheit
PHARM 119 Pharmazie
MI 739 Binnenmarkt
COMPET 840 Wettbewerbsfähigkeit (Binnenmarkt/Industrie)
CODEC 1705 Mitentscheidungsverfahren
  Aufklappen